by Raynovich Rod | Mar 20, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Biotech and Healthcare ETFs Hit An All Time High–Another Rally Coming Today 3/20 M&A: Recent buy-outs of Cubist (CBST) for $9.5B and Pharmacyclics (PCYC) for $21B have raised the valuation bar. The healthcare sector remains strong and biopharmaceuticals are...
by Raynovich Rod | Feb 25, 2015 | 2024 Rayno Biopharmaceuticals Portfolio
2/27 Friday After a big February biotechs turned red today with major ETFs off about 1%. In light of recent M&A talk about Pharmacyclics, Inc. (PCYC) at Market Cap of $16.6B we will look at other top Mid-Cap biopharmaceutical stocks for comparison to our motif...
by Raynovich Rod | Feb 19, 2015 | 2024 Rayno Tools and Diagnostics Portfolio
Bullish Trend Continues for Mid-Cap Growth Stocks The Life Science Tools and Clinical Diagnostics sector kept pace with major life science ETF performance. Major ETFs (FBT,IBB,XBI) are up about 10% YTD and our top performers are up over 10%. We will provide an update...
by Raynovich Rod | Feb 10, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Energy Stocks Down-Biotech and Healthcare Stocks Are Leaders NASDAQ Up 1.30% 4787 After a few days in the doldrums biotech stocks rallied across the board escaping the drag of macro news. Healthcare and technology sectors were among the leaders of the day moving...
by Raynovich Rod | Feb 4, 2015 | 2024 Rayno Biopharmaceuticals Portfolio
2/4/15 After the Bell ECB Impasse with Greece Hits Market Near Close…….. NASDAQ 4221 Down 0.19% Oil Plunges 9% to $48.74 on Inventory Rise Biotech Stocks Try To Recover But Get Hit By ECB News At Close ETFs down about 1.6% , XBI Down 1.9%, XLV down 1.24%...
by Raynovich Rod | Jan 27, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
3:55 p FEDspeak confuses markets with S&P down 1.25% Too much money around too little yield=deflation concerns. Energy takes a big hit again down 4%. Biotechs off 2% and more. ——— Update 1/28 Technology outperforming biotech in mid-day trading...
by Raynovich Rod | Jan 26, 2015 | 2024 Rayno Biopharmaceuticals Portfolio
1/27 Sell-Off Likely Today –Durable Goods Decreased 3.4% In December Green Screen In Biotech Despite Flat Market- Mid-Day Trading 12:45 p 1/26 Most Rayno Life Science stocks were up today in a mixed market where energy is the leading sector. XBI New High at...
by Raynovich Rod | Jan 7, 2015 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
2015: Another Good Year Unless “Something Happens” Life Science stocks had another big year in 2014 up 48% tracking gains for the overall healthcare sector up 35%. Over 10 years the return is 300%! The move up was not a straight line as there were two...
by Raynovich Rod | Dec 22, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
12/24 Technicals are holding in biotech, buyers coming in, GILD up 2.8% . Update 12/23 Second day of Sell-Off …. Caution Biotech stocks sold off hard for the second day with the “best and biggest” down 3-4%. Analyst reports were circulating about...
by Raynovich Rod | Oct 9, 2014 | Biopharmaceuticals, Macro
Five Year Bull Market in Biotech We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio...